189 related articles for article (PubMed ID: 35473781)
1. Treatment and Outcomes of Acute Myocardial Infarction in Patients With Polymyalgia Rheumatica With and Without Giant Cell Arteritis.
Sokhal BS; Matetić A; Bharadwaj A; Helliwell T; Abhishek A; Mallen CD; Mohamed MO; Mamas MA
Am J Cardiol; 2022 Jul; 174():12-19. PubMed ID: 35473781
[TBL] [Abstract][Full Text] [Related]
2. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
4. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
5. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States.
Michailidou D; Zhang T; Stamatis P; Ng B
J Intern Med; 2022 May; 291(5):665-675. PubMed ID: 34982490
[TBL] [Abstract][Full Text] [Related]
7. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
8. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
9. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
10. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
[TBL] [Abstract][Full Text] [Related]
11. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
12. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
16. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
[TBL] [Abstract][Full Text] [Related]
18. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.
Manzo C; Maslinska M; Castagna A; Hysa E; Merante A; Milchert M; Gravina T; Sargin B; Natale M; Ruberto C; Ruotolo G
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917502
[No Abstract] [Full Text] [Related]
19. The incidence and characteristics of giant cell arteritis in Hispanics and the associated outcomes of ischemic ocular events and stroke.
Smith LM; Alvarado LA; Dihowm F
J Investig Med; 2023 Apr; 71(4):411-418. PubMed ID: 36710498
[TBL] [Abstract][Full Text] [Related]
20. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.
Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T
Semin Arthritis Rheum; 2022 Aug; 55():152017. PubMed ID: 35537222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]